FindTrial
Sign In

Product Name: Cyclosporine A episcleral implant

2 trials

Sponsors

Lux Biosciences, Inc.

Conditions

Patient after penetrating keratoplasty who are at increased immunological risk for corneal allograft rejection episodes and/or graft failure MedDRA version: 9.1 Level: LLT Classification code 10011017 Term: Corneal graft rejectionPatient after penetrating keratoplasty who have experienced one or more rejection episodes MedDRA version: 9.1 Level: LLT Classification code 10011017 Term: Corneal graft rejection

Unknown Phase

A MULTI-CENTER, PLACEBO-CONTROLLED, RANDOMIZED, PARALLEL-GROUP DOSE-RANGING STUDY TO ASSESS THE EFFICACY AND SAFETY OF LX201 FOR PREVENTION OF CORNEAL ALLOGRAFT REJECTION EPISODES AND GRAFT FAILURE FOLLOWING PENETRATING KERATOPLASTY WITH LX201 IMPLANTATION IN SUBJECTS WHO ARE AT INCREASED IMMUNOLOGICAL RISK
Active, not recruitingEUCTR2007-000295-16-DE
Lux Biosciences, Inc.Patient after penetrating keratoplasty who are at increased immunological risk for corneal allograft rejection episodes and/or graft failure MedDRA version: 9.1 Level: LLT Classification code 10011017 Term: Corneal graft rejection
Start: 2007-07-27Target: 350Updated: 2012-03-19
A MULTI-CENTER, PLACEBO-CONTROLLED, RANDOMIZED, PARALLEL-GROUP, DOSE-RANGING STUDY TO ASSESS THE EFFICACY AND SAFETY OF LX201 IMPLANTATION FOR THE PREVENTION OF CORNEAL ALLOGRAFT REJECTION EPISODES OR GRAFT FAILURE IN SUBJECTS WHO HAVE EXPERIENCED ONE OR MORE REJECTION EPISODES FOLLOWING PENETRATING KERATOPLASTY
Active, not recruitingEUCTR2007-000294-33-DE
Lux Biosciences, Inc.Patient after penetrating keratoplasty who have experienced one or more rejection episodes MedDRA version: 9.1 Level: LLT Classification code 10011017 Term: Corneal graft rejection
Start: 2007-07-27Target: 400Updated: 2012-10-16